T. Rowe Price Associates’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $309M | Buy |
|
|||||
|
2025
Q2 | $274M | Sell |
|
|||||
|
2025
Q1 | $228M | Buy |
|
|||||
|
2024
Q4 | $189M | Buy |
|
|||||
|
2024
Q3 | $171M | Sell |
|
|||||
|
2024
Q2 | $208M | Sell |
|
|||||
|
2024
Q1 | $306M | Buy |
|
|||||
|
2023
Q4 | $274M | Buy |
|
|||||
|
2023
Q3 | $212M | Sell |
|
|||||
|
2023
Q2 | $304M | Sell |
|
|||||
|
2023
Q1 | $350M | Sell |
|
|||||
|
2022
Q4 | $384M | Sell |
|
|||||
|
2022
Q3 | $547M | Sell |
|
|||||
|
2022
Q2 | $619M | Sell |
|
|||||
|
2022
Q1 | $845M | Sell |
|
|||||
|
2021
Q4 | $774M | Buy |
|
|||||
|
2021
Q3 | $713M | Buy |
|
|||||
|
2021
Q2 | $741M | Buy |
|
|||||
|
2021
Q1 | $586M | Buy |
|
|||||
|
2020
Q4 | $482M | Buy |
|
|||||
|
2020
Q3 | $408M | Buy |
|
|||||
|
2020
Q2 | $419M | Sell |
|
|||||
|
2020
Q1 | $399M | Buy |
|
|||||
|
2019
Q4 | $288M | Buy |
|
|||||
|
2019
Q3 | $222M | Buy |
|
|||||
|
2019
Q2 | $198M | Buy |
|
|||||
|
2019
Q1 | $192M | Buy |
|
|||||
|
2018
Q4 | $177M | Buy |
|
|||||
|
2018
Q3 | $187M | Sell |
|
|||||
|
2018
Q2 | $177M | Buy |
|
|||||
|
2018
Q1 | $112M | Sell |
|
|||||
|
2017
Q4 | $119M | Buy |
|
|||||
|
2017
Q3 | $60.1M | Buy |
|
|||||
|
2017
Q2 | $66.4M | Buy |
|
|||||
|
2017
Q1 | $66.2M | Sell |
|
|||||
|
2016
Q4 | $64.2M | Sell |
|
|||||
|
2016
Q3 | $107M | Sell |
|
|||||
|
2016
Q2 | $232M | Sell |
|
|||||
|
2016
Q1 | $436M | Buy |
|
|||||
|
2015
Q4 | $459M | Sell |
|
|||||
|
2015
Q3 | $402M | Buy |
|
|||||
|
2015
Q2 | $388M | Buy |
|
|||||
|
2015
Q1 | $412M | Sell |
|
|||||
|
2014
Q4 | $398M | Sell |
|
|||||
|
2014
Q3 | $787M | Sell |
|
|||||
|
2014
Q2 | $732M | Buy |
|
|||||
|
2014
Q1 | $699M | Buy |
|
|||||
|
2013
Q4 | $509M | Buy |
|
|||||
|
2013
Q3 | $88.2M | Buy |
|
|||||
|
2013
Q2 | $28.6M | Buy |
|